[Thrombosis in spite of warfarin--what should be done?].
Lassila
R
R
HYKS, Meilahden sairaala Sisätautien toimiala Wihurin tutkimuslaitos PL 340, 00029 HUS. riitta.lassila@hus.fi
D000925:Anticoagulants / Q000627:therapeutic use*; D016736:Antiphospholipid Syndrome / Q000150:complications; D001384:Azetidines; D001596:Benzylamines; D001777:Blood Coagulation / Q000187:drug effects; D005998:Glycine / Q000031:analogs & derivatives* / Q000627:therapeutic use; D006495:Heparin, Low-Molecular-Weight / Q000627:therapeutic use; D006801:Humans; D019934:International Normalized Ratio; D009369:Neoplasms / Q000150:complications; D012008:Recurrence; D013917:Thrombin / Q000037:antagonists & inhibitors; D013927:Thrombosis / Q000188:drug therapy* / Q000209:etiology; D017211:Treatment Failure; D014859:Warfarin / Q000627:therapeutic use*
D000925:Anticoagulants; D001384:Azetidines; D001596:Benzylamines; D006495:Heparin, Low-Molecular-Weight; C109573:melagatran; D014859:Warfarin; D013917:Thrombin; D005998:Glycine